SRPT
Sarepta Therapeutics, Inc.
$117.89
Earnings Summary
Revenue | $396.78Mn |
Net Profits | $45.66Mn |
Net Profit Margins | 11.51% |
Highlights
Sarepta Therapeutics, Inc.’s revenue jumped 53.54% since last year same period to $396.78Mn in the Q4 2023. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 19.58% jump in its revenue since last 3-months.
Sarepta Therapeutics, Inc.’s net profit jumped 141.79% since last year same period to $45.66Mn in the Q4 2023. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 211.53% jump in its net profits since last 3-months.
Sarepta Therapeutics, Inc.’s net profit margin jumped 127.22% since last year same period to 11.51% in the Q4 2023. On a quarterly growth basis, Sarepta Therapeutics, Inc. has generated 193.27% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Sarepta Therapeutics, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.07 |
EPS Estimate Current Year | -0.07 |
Highlights
Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.07 - a -800% fall from last quarter’s estimates.
Sarepta Therapeutics, Inc.’s earning per share (EPS) estimates for the current year stand at -0.07.
Key Ratios
Key ratios of the Sarepta Therapeutics, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | 0.47 |
Highlights
Sarepta Therapeutics, Inc.’s earning per share (EPS) jumped 137.9% since last year same period to 0.47 in the Q4 2023. This indicates that the Sarepta Therapeutics, Inc. has generated 137.9% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-02 | -1.38 | -5.86 | -324.64% |
2023-08-02 | -1.78 | -0.27 | 84.83% |
2023-11-01 | -1.23 | -0.46 | 62.6% |
2024-02-28 | 0.01 | 0.47 | 4600% |
₹0 US Stocks a/c Opening Fee